A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer|Prostate Cancer|Colon Cancer|Renal Cancer
Interventions: DRUG: Cyclophosphamide & ZYC300 (ZYC300 with cyclophosphamide pre-dosing)
Sponsor: Eisai Inc.